Oxypro 15mg modified-release tablets
BNF presentation 0407020ADBSACAS within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBSACAS
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
5,615
NHS spend (£)
£39,148.11
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 894 |
| February 2025 | 10 |
| December 2024 | 277 |
| November 2024 | 1,040 |
| October 2024 | 1,035 |
| September 2024 | 29 |
| August 2024 | 76 |
| July 2024 | 1,048 |
| May 2024 | 256 |
| July 2021 | 159 |
| June 2021 | 101 |
| December 2020 | 335 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 95 | No data available |
| Unknown pharmacy | 78 | No data available |
| Unknown pharmacy | 73 | No data available |
| Unknown pharmacy | 61 | No data available |
| Unknown pharmacy | 45 | No data available |
| Unknown pharmacy | 43 | No data available |
| Unknown pharmacy | 38 | No data available |
| Unknown pharmacy | 34 | No data available |
| Unknown pharmacy | 31 | No data available |
| Unknown pharmacy | 30 | No data available |